SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001694665-22-000069
Filing Date
2022-04-26
Accepted
2022-04-26 16:25:37
Documents
4
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A evelo-proxystatementfor202.htm DEF 14A 619674
2 newevlologoa.jpg GRAPHIC 6176
3 proxycard040522_pagex1a.jpg GRAPHIC 532573
4 proxycard040522_pagex2a.jpg GRAPHIC 227080
  Complete submission text file 0001694665-22-000069.txt   1674950
Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38473 | Film No.: 22854705
SIC: 2834 Pharmaceutical Preparations